00006-4119
GARDASIL 9
Human Papillomavirus 9-valent Vaccine, Recombinant
INJECTION, SUSPENSION
Intramuscular
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
40.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN
60.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
40.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
30.0
ug/.5mL
00006-4119-01
Dec. 10, 2014

00006-4119-02
1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-02) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01)
Dec. 10, 2014
May 22, 2019

00006-4119-03
10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-03) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01)
Dec. 10, 2014
Ancillary Therapy
Protective Agent
HPV Vaccine
 
In Use